Lilly Has The Upper Hand In Obesity In 2025 But Novo Has More Cards To Play

2024-2025 Scrip Perspectives
(Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from R&D